Manufacturing of Human Extracellular Vesicle-Based Therapeutics for Clinical Use
Extracellular vesicles (EVs) derived from stem and progenitor cells may have therapeutic effects comparable to their parental cells and are considered promising agents for the treatment of a variety of diseases. To this end, strategies must be designed to successfully translate EV research and to de...
Main Authors: | Mario Gimona, Karin Pachler, Sandra Laner-Plamberger, Katharina Schallmoser, Eva Rohde |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2017-06-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/1422-0067/18/6/1190 |
Similar Items
-
An In Vitro Potency Assay for Monitoring the Immunomodulatory Potential of Stromal Cell-Derived Extracellular Vesicles
by: Karin Pachler, et al.
Published: (2017-07-01) -
Mesenchymal Stromal Cell-Based Bone Regeneration Therapies: From Cell Transplantation and Tissue Engineering to Therapeutic Secretomes and Extracellular Vesicles
by: Darja Marolt Presen, et al.
Published: (2019-11-01) -
Extracellular Vesicles Can Deliver Anti-inflammatory and Anti-scarring Activities of Mesenchymal Stromal Cells After Spinal Cord Injury
by: Pasquale Romanelli, et al.
Published: (2019-11-01) -
Small extracellular vesicles released by infused mesenchymal stromal cells target M2 macrophages and promote TGF‐β upregulation, microvascular stabilization and functional recovery in a rodent model of severe spinal cord injury
by: Masahito Nakazaki, et al.
Published: (2021-09-01) -
Extracellular vesicles from human multipotent stromal cells protect against hearing loss after noise trauma in vivo
by: Athanasia Warnecke, et al.
Published: (2020-12-01)